New IV treatment aims to boost platelets in ITP patients

NCT ID NCT06962631

First seen Jan 26, 2026 · Last updated May 14, 2026 · Updated 16 times

Summary

This study tests a medicine called V-IMMUNE® (human immunoglobulin given through a vein) to see if it can safely raise platelet counts in people with immune thrombocytopenia (ITP), a condition where the immune system destroys platelets, causing bleeding risks. About 31 adults and children aged 1 year and older with very low platelet counts (20,000 or less) will receive two daily infusions. The main goal is to see if platelet counts reach a safe level (50,000 or higher) by day 9 after treatment.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for IMMUNE THROMBOCYTOPENIA (ITP) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • IMIP Instituto de Medicina Integral Professor Fernando Figueira

    NOT_YET_RECRUITING

    Recife, Pernambuco, 50070-902, Brazil

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

  • Santa Casa de Misericórida de São Paulo

    RECRUITING

    São Paulo, São Paulo, 01221020, Brazil

    Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.